A Pilot Study of Brentuximab Vedotin, Rituximab and Dose Attenuated CHP in Patients 75 Years and Older with Diffuse Large B-Cell Lymphoma

被引：2
|
作者：
Reagan, Patrick M.
Portell, Craig A.
Casulo, Carla
Baran, Andrea M.
Magnuson, Allison
Barr, Paul M.
Lerman, Yelena
French, Krista N.
Friedberg, Jonathan W.
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140384
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Zanubrutinib, Polatuzumab Vedotin and Rituximab (ZPR) Combination Regimen for Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
    Zhang, Yian
    Yuan, Ling
    Zhuang, Jingli
    Wang, Zhimei
    Zhang, Xuejiao
    Wang, Weiguang
    Liu, Peng
    BLOOD, 2023, 142
  • [22] US cost-effectiveness of polatuzumab vedotin, bendamustine and rituximab in diffuse large B-cell lymphoma
    Betts, Keith A.
    Thuresson, Per-Olof
    Felizzi, Federico
    Du, Ella X.
    Dieye, Ibou
    Li, Jia
    Schulz, Mathias
    Masaquel, Anthony S.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (14) : 1003 - 1015
  • [23] Role of Rituximab and Rituximab Biosimilars in Diffuse Large B-Cell Lymphoma
    Coleman, Morton
    Lammers, Philip E.
    Ciceri, Fabio
    Jacobs, Ira A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (04): : 175 - 181
  • [24] Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
    Habermann, Thomas M.
    Weller, Edie A.
    Morrison, Vicki A.
    Gascoyne, Randy D.
    Cassileth, Peter A.
    Cohn, Jeffrey B.
    Dakhil, Shaker R.
    Woda, Bruce
    Fisher, Richard I.
    Peterson, Bruce A.
    Horning, Sandra J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3121 - 3127
  • [25] Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
    Habermann, T
    Weller, E
    Morrison, V
    Gascoyne, R
    Cassileth, P
    Cohn, J
    Dakhil, S
    Woda, B
    Fisher, R
    Peterson, B
    Horning, S
    ANNALS OF ONCOLOGY, 2005, 16 : 103 - 103
  • [26] Pilot study of dacetuzumab in combination with rituximab and gemcitabine for relapsed or refractory diffuse large B-cell lymphoma
    Forero-Torres, Andres
    Bartlett, Nancy
    Beaven, Anne
    Myint, Han
    Nasta, Sunita
    Northfelt, Donald W.
    Whiting, Nancy C.
    Drachman, Jonathan G.
    LoBuglio, Albert F.
    Moskowitz, Craig H.
    LEUKEMIA & LYMPHOMA, 2013, 54 (02) : 277 - 283
  • [27] A Phase 2 Study of Zilovertamab Vedotin With Cyclophosphamide, Doxorubicin, and Prednisone Plus Rituximab (R-CHP) in Diffuse Large B-Cell Lymphoma: waveLINE-007
    David, Lavie
    Muhit, Ozcan
    Ewa, Paszkiewicz-Kozik
    Eva, Gonzalez Barca
    Min, Kim Tae
    Benedetta, Puccini
    Siruo, Wang
    Rushdia, Yusuf
    Patricia, Marinello
    Seog, Kim Won
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S31 - S32
  • [28] Treatment Choice and Outcome In Diffuse Large B Cell Lymphoma (DLBCL) Patients 75 Years and Older
    Toomey, Christina E.
    Muzikanksy, Alona
    Lee, Alfred Ian
    Barnes, Jeffrey A.
    Michaelson, James S.
    Abramson, Jeremy S.
    Hochberg, Ephraim P.
    BLOOD, 2010, 116 (21) : 323 - 324
  • [29] Polatuzumab vedotin in relapsed/refractory diffuse large B-cell lymphoma
    Dietliker, N.
    Kiesel, H.
    Mueller, R.
    Mueller, A. M.
    Manz, M. G.
    Zenz, T.
    Rosler, W.
    SWISS MEDICAL WEEKLY, 2020, : 21S - 21S
  • [30] Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
    Tilly, Herve
    Morschhauser, Franck
    Sehn, Laurie H.
    Friedberg, Jonathan W.
    Trneny, M.
    Sharman, Jeff P.
    Herbaux, Charles
    Burke, John M.
    Matasar, Matthew
    Rai, Shinya
    Izutsu, Koji
    Mehta-Shah, Neha
    Oberic, Lucie
    Chauchet, Adrien
    Jurczak, Wojciech
    Song, Yuqin
    Greil, Richard
    Mykhalska, Larysa
    Bergua-Burgues, Juan M.
    Cheung, Matthew C.
    Pinto, Antonio
    Shin, Ho-Jin
    Hapgood, Greg
    Munhoz, Eduardo
    Abrisqueta, Pau
    Gau, Jyh-Pyng
    Hirata, Jamie
    Jiang, Yanwen
    Yan, Mark
    Lee, Calvin
    Flowers, Christopher R.
    Salles, Gilles
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04): : 351 - 363
12345